Background-Obesity may be an important risk factor for end-stage renal disease (ESRD) but the association between the obesity measure waist circumference (WC) and ESRD remains poorly explored.
Introduction
Obesity is associated with chronic kidney disease (CKD) among adults and is an important risk factor for the development of end-stage renal disease (ESRD), defined as kidney failure requiring dialysis or transplantation. [1] [2] [3] [4] [5] [6] The association between obesity and kidney disease remains poorly understood and may be mediated by well-known risk factors for CKD that are shared with obesity including diabetes 3, 5, 7 and hypertension. [8] [9] [10] [11] Fairly weak associations are noted between obesity, as defined by an elevated BMI, and early stages of incident CKD. 3, 4, 12 Obesity may be estimated by body mass index (BMI), waist circumference (WC), waist-to-hip ratio or with direct measures of total body fat. In population-based studies and clinical practice, obesity is often assessed by an individual's BMI. However, BMI is a composite measure of muscle mass, peripheral and abdominal adipose tissue and bone mass. The lack of specificity of BMI may account for the weak and inconsistent associations noted between incident CKD and obesity as assessed by BMI. 3, 4, [12] [13] [14] [15] with decreased mortality. 20 This study examines the associations between obesity, as measured by BMI or WC, and incident ESRD in the population-based REasons for Geographic And Racial Differences in Stroke (REGARDS) cohort study.
Methods

Participants
The REGARDS study is a population-based prospective cohort of individuals aged 45 years and older designed to study reasons for the higher stroke mortality among blacks versus whites and in the Southeast region of the US. 21, 22 REGARDS is a cohort study of a national sample, 20.9% of whom reside in the coastal plain of North Carolina (NC), South Carolina (SC), and Georgia (GA), 34 .5% in the remainder of NC, SC, and GA and the southeastern states of Tennessee, Mississippi, Alabama, Louisiana and Arkansas, and 44.5% in the other 42 contiguous states. Black adults were oversampled; a total of 30,239 adults were recruited into the cohort between January 2003 and October 2007. Baseline data collection included a telephone interview followed by an in-home physical examination by trained staff. 21 The physical exam included anthropomorphic measures (weight, height and WC), phlebotomy, and collection of a spot urine specimen. We excluded 3,279 participants, 10.8% of the cohort, who were missing data on the albumin-to-creatinine ratio (ACR), serum creatinine, BMI or WC measurements, or who had a BMI < 18.5 kg/m 2 , an eGFR < 15 ml/min/1.73 m 2 , or reported being treated for ESRD during the baseline telephone interview. The REGARDS study was approved by the institutional review boards of the participating institutions, and all participants provided verbal consent before the telephone interview was conducted and written informed consent before completion of the in-home study visit.
Kidney Function
Serum creatinine was calibrated to an international isotope dilution mass spectroscopic (IDMS)-traceable standard, measured by colorimetric reflectance spectrophotometry (Ortho Vitros Clinical Chemistry System 950IRC. Estimated glomerular filtration rate (eGFR) was calculated using the CKD-EPI equation. 23 Albumin and creatinine were measured in a random spot urine specimen by nephelometry (BN ProSpec Nephelometer, Dade Behring, Marburg, Germany) and Modular-P chemistry analyzer (Roche/Hitachi, Indianapolis, IN), respectively. A spot urine ACR was calculated and moderate to severely increased urine albumin excretion was defined as an ACR ≥ 30 mg/g. Incident cases of ESRD were identified through linkage of REGARDS study participants with the United States Renal Data System (USRDS). This analysis included incident ESRD cases through August 31, 2012. The USRDS is a registry of ESRD and captures over 95% of all incident ESRD cases in the U.S.
Obesity Measures
BMI was calculated as weight (kg)/height (m 2 ) and categorized as 18.5-24.9 (ideal); 25.0-29.9 (overweight), 30.0-34.9 (class I obesity), 35.0-39.9 (class II obesity) and ≥ 40 (class III obesity). 24 Waist circumference was measured mid-way between the lowest rib and the iliac crest using a tape measure with the participant standing and was categorized in cm as < 80 in women and < 94 in men (referent group), 80-87.9 in women and 94-101.9 in men, 88-97.9 in women and 102-111.9 in men, 98-107.9 in women and 112-121.9 in men, and ≥ 108 in women and ≥ 122 in men. 24 
Covariates
Coronary artery disease, stroke, smoking status, education, and family income were ascertained by self-report during the telephone interview. Hypertension was defined as either self-reported use of antihypertensive medications or a systolic blood pressure (SBP) ≥ 140 mm Hg or a diastolic blood pressure (DBP) ≥ 90 mm Hg measured during the home examination, where SBP and DBP were the average of two measures taken in the seated position. We defined diabetes as a fasting glucose ≥ 126 mg/dL, or a non-fasting glucose ≥ 200 mg/dL, or current use of either oral hypoglycemic pills or insulin.
Statistical Analysis
Univariate statistics are reported as mean ± standard deviation (SD) or counts and proportions. Cox proportional hazards models were used to determine the independent associations between BMI and WC categories with ESRD. Follow-up time was censored at development of ESRD, death, or date of last follow-up phone contact, whichever occurred first. Separate models were created to examine BMI and WC as independent variables. Sequential models were created to examine changes in the parameter estimates with the adjustment for BMI or WC (Model 2), for obesity associated co-morbidities (Model 3) and for ACR (Model 4). Model 1 adjusted for age, sex, race, sampling region, household income and education. Model 2 then included WC or BMI as a covariate and Model 3 further adjusted for the presence of co-morbid conditions (coronary heart disease, stroke, hypertension and diabetes), and baseline eGFR. Model 4 then added log transformed baseline ACR to Model 3. The referent group was the lowest BMI group (BMI 18.5-24.9 kg/m 2 ) for the analyses with BMI as the main independent variable and the lowest WC group (< 80 cm in women and < 94 cm in men) for the analysis with WC as the main independent variable. We tested for trends for ESRD risk across BMI and WC categories by substituting interval measures of these covariates.
Co-linearity between the categorical measures of BMI and WC was first tested by calculating the Spearman rank correlation coefficient between the two measures and then by calculating the tolerance value, which estimates the proportion of variance in a given predictor that is not explained by the other. Although BMI and WC were correlated (r=0.7877, p<0.0001), formal tests for co-linearity between WC and BMI showed a tolerance value of 0.3976. The reciprocal of the tolerance value (variance inflation factor) was 2.6346 with values ≥ 5 generally indicating co-linearity. 25 The assumptions of the Cox proportional hazards models were examined by plotting the natural log of the cumulative hazard of ESRD by the natural log of time. A two sided p value of 0.05 was considered statistically significant. less than a high school education. Annual household income was reported as less than $20,000 by 17.3% of participants. The prevalence of co-morbid conditions included previous stroke in 6.0%, coronary heart disease in 17.4%, hypertension in 58.8% and diabetes in 20.7%. The mean (SD) WC was 92.8 (15.7) cm and 100.2 (13.2) cm among women and men, respectively (p<0.001), while mean BMI was 30.0 (6.8) kg/m 2 and 28.6 (4.9) kg/m 2 among men and women, respectively (p<0.001). Tables 1a and 1b show the baseline characteristics by BMI and WC categories. As BMI and WC increased, individuals tended to be younger, more likely to be female and black, have lower educational attainment and household income, and have increased prevalence of diabetes and hypertension (all p<0.001). The percentage of participants aged ≥ 65 years ranged from as high as 52.2% in the lowest BMI category to 6.3% in the highest BMI category. Across WC categories, the percentage of participants aged ≥ 65 years ranged from 48.3% among women and men with WC 88.0-97.9 cm and 102-111.9 cm, respectively, to 35.7% among women and men with WC ≥ 108 cm and ≥ 122 cm, respectively.
Albuminuria was noted in 18.9% of participants while 14.8% had an eGFR< 60 ml/min/ 1.73m 2 . Figure 1 shows the percentage of participants with moderate to severely increased ACR and eGFR < 60 ml/min/1.73 m 2 by BMI and WC categories. Prevalence of both moderate to severely increased ACR and eGFR < 60 ml/min/1.73 m 2 differed significantly by BMI and WC categories (p < 0.001 for all comparisons). Among participants in the highest BMI category, 20.7% had moderate to severely increased urine albumin excretion and 12.0% had eGFR < 60 ml/min/1.73 m 2 . In the highest WC category, 22.5% had moderate to severely increased urine albumin excretion and 13.2% had eGFR < 60 ml/min/ 1.73 m 2 .
Overall, 297 individuals developed ESRD (1.1%) during a median (interquartile range) follow-up of 6.3 (5.1 to 7.6) years. Table 2 shows the frequency and incidence rate of ESRD by BMI and WC categories. ESRD rates ranged from as low as 113.5 cases per 100,000 person-years among those with BMI between 18.5 -24.9 kg/m 2 to as high as 212.4 cases per 100,000 person-years among those with BMI between 35.0-39.9 kg/m 2 . ESRD rates showed a fairly linear increase across increasing WC categories from 83.6 cases per 100,000 person-years in the lowest category WC category to 250.6 cases per 100,000 person-years in the highest WC category.
In the model adjusted for age, sex, race, region, income and education, a BMI of 30-34.9, 35-39.9 and ≥ 40 kg/m 2 was associated with higher ESRD incidence compared to the referent group 18.5-24.9 with hazard ratios of 1.41 (95% CI 1.00, 1.99), .1.55 (95% CI 1.03, 2.38), and 1.66 (95% CI 1.02, 2.68), respectively ( Figure 2 ). After adjustment for WC and obesity associated co-morbidities and eGFR, BMI categories ≥ 35 kg/m 2 were associated with significantly lower ESRD risk compared to the referent group with hazard ratios of 0.48 (95% CI 0.27, 0.86) for BMI 35-39.9 kg/m 2 and 0.47 (95% CI 0.24, 0.92) for BMI ≥ 40 kg/m 2 . Further adjustment for ACR led to no significant associations between BMI categories and ESRD incidence.
which adjusted for age, sex, race, region, income and education, all WC categories were associated with significantly higher ESRD risk compared to the referent group. Participants with a WC ≥ 108 cm in women and ≥ 122 cm in men (highest category) had a 2.81 fold higher hazard rate for ESRD (95% CI 1.89, 4.17) compared to the WC referent group (< 80 cm in women and < 94 cm in men). Further adjustment for BMI strengthened the associations between WC categories and ESRD incidence with the highest WC category showing a 3.79 fold higher ESRD rate compared to the referent group (95% CI 2.10, 6.86). However, after adjustment for obesity associated co-morbidities and baseline ACR and eGFR, no significant association was noted between any WC category and ESRD incidence (Figure 2 ).
Discussion
This study demonstrates differences in the associations between BMI and WC with incident ESRD among adults in the general population. In particular, increased WC was associated with a higher rate of ESRD after adjustment for BMI while BMI was not associated with higher ESRD rates after adjustment for WC. Postulated factors which mediate the association between obesity and CKD include inflammation, insulin resistance, 26 activation of the renin-angiotensin-aldosterone 27 and sympathetic nervous systems, 28 increased oxidative stress, 29 and high caloric intake. 30 These factors may lead to hypertension, diabetes and increased urine albumin excretion given the strong link between central adiposity and the metabolic syndrome. [31] [32] [33] [34] A higher risk of CKD mediated by metabolic syndrome and obesity is supported by previous findings from the REGARDS cohort. Panwar et al demonstrated that the association between high BMI and ESRD risk depends on the metabolic health status of the individual. 35 Obesity, as defined by an elevated BMI, was associated with an increased risk for ESRD only among the REGARDS participants with metabolic syndrome. In fact, ESRD risk was lower among obese individuals who were metabolically healthy compared to non-obese individuals with metabolic syndrome. 35 Increased urine albumin excretion reflects an increased risk for both ESRD and mortality 36 with significantly increased risk noted with ACR levels > 10 mg/g. 37 . In this study, the association between WC and ESRD was attenuated after adjustment for obesity related comorbidities and baseline ACR levels. Our findings are similar to results from a subcohort of Women's Health Initiative (WHI), which included 20, 117 postmenopausal women with a mean follow-up period of 11.6 years. 38 The mean age of this WHI cohort was 63.9 years at baseline and 38.3% were African American; WC was categorized as > 88 cm vs. ≤ 88 cm. After adjustment for age, baseline eGFR, race, education, smoking status, and site, a WC > 88 cm was associated with a 2.68 fold higher rate of ESRD compared to WC ≤ 88 cm. However, this association was markedly attenuated after adjustment for diabetes and hypertension (HR 1.49; 95% CI 1.08, 2.06). In REGARDS, abdominal adiposity as measured by WC was associated with significantly higher risk of ESRD compared to the referent group but this association was no longer statistically significant after adjustment for obesity associated co-morbidities, eGFR and ACR. It should be noted that these analyses of WC and ESRD in the WHI subcohort did not include ACR as a covariate because it was not available. The overall prevalence of morbid obesity (WC ≥ 108 cm in Women and ≥ 122 cm in men or BMI ≥ 40 kg/m 2 ) in the REGARDS cohort was substantially higher among women compared to men, findings which reflect sex differences in severe obesity prevalence in the total U.S. adult population. 39 Elevated BMI has previously been shown to be associated with incident ESRD. 5, 7 Hsu and his associates examined the relationship between BMI and incident ESRD in over 300,000 subjects who volunteered for screening health checkups during years 1964-1985 in a large health care system and were followed for 15-34 years. 5 They demonstrated that among individuals with baseline kidney disease, a BMI ≥ 40 kg/m 2 was associated with a 3-fold higher risk of ESRD compared to individuals with an ideal BMI (18.5-24.9 kg/m 2 ). This association was even stronger among adults without CKD at baseline. 5 The discrepant findings between the study by Hsu et al and this study which focused on REGARDS participants may reflect one or more factors. Participants in the study by Hsu et al were young, (between the ages of 18 to 34 years at baseline) and fairly lean with over half of the participants having an ideal BMI at baseline. In contrast, the baseline mean age of the REGARDS participants was 64.8 years and the average baseline BMI was 29 kg/m 2 with the majority of REGARDS participants being either overweight or obese. Also, the length of follow-up, which ranged from 15 to 34 years, in the study by Hsu et al was substantially longer compared to the follow-up period in the REGARDS study. Also, the time period for the cohort utilized in the study by Hsu et al began during years 1964-1985 and treatment of both diabetes and hypertension has changed dramatically since the 1980s. Finally, our fully adjusted models accounted for WC and ACR. While these factors may all account for the differing associations between BMI categories and incident ESRD noted between these two studies, clearly further examination of the associations between BMI, WC and ESRD in younger populations is warranted.
The limitations of this study include the limited follow-up period which may have been too short to adequately assess ESRD risk among adults with an eGFR > 60 ml/min/1.73 m 2 . Collinearity between WC and BMI may have influenced the parameter estimates for the associations between obesity measures and ESRD incidence that are adjusted for BMI or WC. However, the inverse association between obesity as measured by BMI and ESRD risk after adjustment for WC may be due to the fact that BMI reflects not only peripheral and abdominal adiposity but also muscle mass. The associations between BMI and WC and ESRD mirror associations previously shown between these adiposity measures and mortality in the REGARDS cohort. 20 In participant data pooled from the Atherosclerosis Risk in Communities Study and the Cardiovascular Health Study, obesity measured by waist-to-hip ratios was associated with higher mortality while obesity measured by BMI was not. 40 The strengths of this study include the large number of both white and black adults with a wide range of socioeconomic backgrounds who were recruited from the Southeast and other U.S. regions. Additional studies are needed to investigate associations between adiposity measures and ESRD risk in other racial/ethnic groups such as Hispanics and Asians.
Increased WC is associated with heightened risk of ESRD while higher BMI is associated with lower ESRD risk after adjustment for WC. The association between increased WC and ESRD appears to be mediated by obesity related co-morbidities and higher ACR values. Kramer 
